Azenta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
August 09, 2022 at 04:20 pm
Share
Azenta, Inc. reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported revenue was USD 132.74 million compared to USD 129.09 million a year ago. Net loss was USD 9.57 million compared to net income of USD 39.17 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 0.02 a year ago. Basic loss per share was USD 0.13 compared to basic earnings per share of USD 0.53 a year ago. Diluted loss per share was USD 0.13 compared to diluted earnings per share of USD 0.53 a year ago.
For the nine months, revenue was USD 417.93 million compared to USD 376.76 million a year ago. Net income was USD 2,153.62 million compared to USD 88.94 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.09 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.09 a year ago. Basic earnings per share was USD 28.76 compared to USD 1.2 a year ago. Diluted earnings per share was USD 28.76 compared to USD 1.2 a year ago.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.